Table 1: Study cohort.

244
Age (years), mean ± std66.2 ± 6.48
PSA (ng/mL), mean ± std10.8 ± 9.22
Clinical stage, (%)
 T1c181 (74.2)
 T2a45 (18.4)
 T2b10 (4.1)
 T2c8 (3.3)
Preoperative Gleason score, (%)
 ≤6123 (50.4)
 794 (38.5)
 ≥827 (11.1)
Neurovascular spare, (%)
 Yes141 (57.8)
 No103 (42.2)
Pathological stage, (%)
 T2a28 (11.5)
 T2b9 (3.7)
 T2c140 (57.4)
 T3a39 (16.0)
 T3b28 (11.5)
Postoperative Gleason score, (%)
 ≤694 (38.5)
 7110 (45.1)
 ≥840 (16.4)
Surgical margins, (%)
 Positive44 (18.0)
 Negative200 (82.0)
Biochemical relapse, (%)
 Yes39 (16.0)
 No205 (84.0)

Std: standard deviation.